Prostate Cancer Screening Urgently Needed, Says Former Prime Minister Sunak
Ex-government leader Sunak has strengthened his appeal for a focused screening programme for prostate cancer.
During a recently conducted conversation, he declared being "persuaded of the critical importance" of establishing such a programme that would be economical, feasible and "preserve numerous lives".
His remarks emerge as the UK National Screening Committee reviews its ruling from five years ago declining to suggest routine screening.
Media reports indicate the committee may continue with its current stance.
Athlete Adds Support to Campaign
Champion athlete Sir Hoy, who has advanced prostate gland cancer, supports men under 50 to be checked.
He proposes decreasing the eligibility age for accessing a PSA blood screening.
Currently, it is not routinely offered to healthy individuals who are younger than fifty.
The PSA examination is controversial though. Readings can rise for factors apart from cancer, such as infections, causing incorrect results.
Opponents argue this can result in unwarranted procedures and adverse effects.
Focused Testing Initiative
The suggested examination system would target men aged 45–69 with a family history of prostate gland cancer and men of African descent, who encounter twice the likelihood.
This population comprises around 1.3 million individuals in the UK.
Charity estimates suggest the initiative would necessitate £25 million annually - or about eighteen pounds per participant - comparable to intestinal and breast testing.
The estimate includes 20% of eligible men would be invited yearly, with a nearly three-quarters uptake rate.
Diagnostic activity (scans and biopsies) would need to rise by almost a quarter, with only a reasonable growth in medical workforce, as per the study.
Medical Community Reaction
Several clinical specialists are uncertain about the benefit of examination.
They assert there is still a possibility that individuals will be intervened for the condition when it is not strictly necessary and will then have to endure complications such as urinary problems and erectile dysfunction.
One respected urological expert commented that "The problem is we can often identify abnormalities that might not necessitate to be addressed and we risk inflicting harm...and my apprehension at the moment is that negative to positive ratio isn't quite right."
Individual Experiences
Personal stories are also influencing the debate.
A particular instance involves a sixty-six year old who, after asking for a blood examination, was identified with the disease at the time of fifty-nine and was advised it had progressed to his hip region.
He has since received chemical therapy, radiation treatment and hormonal therapy but is not curable.
The individual supports testing for those who are at higher risk.
"This is essential to me because of my sons – they are approaching middle age – I want them tested as soon as possible. If I had been examined at fifty I am certain I wouldn't be in the situation I am today," he stated.
Future Steps
The Medical Screening Authority will have to weigh up the information and perspectives.
Although the new report indicates the ramifications for workforce and availability of a screening programme would be achievable, some critics have argued that it would take imaging resources otherwise allocated to patients being managed for alternative medical problems.
The current dialogue highlights the multifaceted trade-off between early detection and likely overtreatment in prostate cancer management.
